Balsan S
Ann Endocrinol (Paris). 1981 Oct-Nov;42(4-5):492-6.
The synthesis of vitamin D derivatives and analogues, more especially that of 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D et l alpha-hydroxyvitamin D has opened a new field of investigation in pediatric pharmacology. These substances allows to achieve replacement therapy in pathological states characterized by a decreased formation of 25-hydroxyvitamin D (hepato-cellular diseases) or, 1, 25-dihydroxyvitamin D (renal diseases). Moreover, their utilisation at pharmacological doses has improved the therapeutic results in a number of pediatric diseases. In the present report are more especially summarized the results obtained with these three derivatives in patients with secondary hyperparathyroidism, hypo or pseudo-hypoparathyroidism.
维生素D衍生物及类似物的合成,尤其是25-羟基维生素D、1,25-二羟基维生素D和α-羟基维生素D的合成,开启了儿科药理学研究的新领域。这些物质能够在以25-羟基维生素D(肝细胞疾病)或1,25-二羟基维生素D(肾脏疾病)生成减少为特征的病理状态下进行替代治疗。此外,它们在药理剂量下的应用改善了多种儿科疾病的治疗效果。在本报告中,特别总结了这三种衍生物在继发性甲状旁腺功能亢进、甲状旁腺功能减退或假性甲状旁腺功能减退患者中所取得的结果。